Nuveen »

Takeda Pharmaceutical shares owned by Nuveen

Quarter-by-quarter ownership of Takeda Pharmaceutical (TAK) shares owned by Nuveen from 13F filings

Historical chart of Nuveen investment in Takeda Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Takeda Pharmaceutical held by Nuveen consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Takeda Pharmaceutical by Nuveen

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.8M 174k 16.03

More positions owned by Nuveen

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Micron Technology (MU)
Applied Materials (AMAT)
Lam Research Corp Com New (LRCX)
Advanced Micro Devices (AMD)

View all positions for Nuveen

Top funds holding Takeda Pharmaceutical

Capital Research Global Investors
FMR
Morgan Stanley
Adage Capital Partners GP
Goldman Sachs Group
Brandes Investment Partners
Arrowstreet Capital, Limited Partnership
BlackRock
Renaissance Technologies
Qube Research & Technologies
First Trust Advisors
D. E. Shaw & Co
Managed Asset Portfolios
Northern Trust
Van Eck Associates Corp.

View all funds holding Takeda Pharmaceutical